Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIT: 2011-2012

Historic EBIT for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$6.5 million.

  • Sonoma Pharmaceuticals' EBIT rose 71.11% to -$680,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$3.5 million, marking a year-over-year increase of 45.88%. This contributed to the annual value of -$6.5 million for FY2012, which is 13.83% up from last year.
  • As of FY2012, Sonoma Pharmaceuticals' EBIT stood at -$6.5 million, which was up 13.83% from -$7.5 million recorded in FY2011.
  • Sonoma Pharmaceuticals' EBIT's 5-year high stood at -$6.5 million during FY2012, with a 5-year trough of -$7.5 million in FY2011.
  • In the last 2 years, Sonoma Pharmaceuticals' EBIT had a median value of -$7.0 million in 2011 and averaged -$7.0 million.
  • Data for Sonoma Pharmaceuticals' EBIT shows a peak YoY climbed of 13.83% (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' EBIT (Yearly) stood at -$7.5 million in 2011, then rose by 13.83% to -$6.5 million in 2012.